ReviewExploration of targeted anti-tumor therapy2022

Clinical utility of liquid biopsy-based companion diagnostics in the non-small-cell lung cancer treatment.

Yoshiharu SatoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.